ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Clinical trials for ACUTE PROMYELOCYTIC LEUKEMIA (APL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA (APL) trials appear
Sign up with your email to follow new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Arsenic pill could replace IV for rare leukemia
Disease control CompletedThis study looked at how an oral liquid form of arsenic trioxide (SDK001) works in 12 people with acute promyelocytic leukemia (APL). Researchers compared it to the standard IV version and checked if food or calcium supplements change how the drug is absorbed. The goal was to fin…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: PHASE1 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 08:48 UTC
-
AI steps in to speed up rare blood cancer diagnosis
Knowledge-focused CompletedThis study tested whether artificial intelligence (AI) can help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Ten doctors reviewed bone marrow samples with and without AI assistance. The goal was to see if AI improves …
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: NA • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC